Cargando…

A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden

Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages defining the natural history of SARS-CoV-2 infection from 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardini, Agnese, Galli, Margherita, Tirani, Marcello, Cereda, Danilo, Manica, Mattia, Trentini, Filippo, Guzzetta, Giorgio, Marziano, Valentina, Piccarreta, Raffaella, Melegaro, Alessia, Ajelli, Marco, Poletti, Piero, Merler, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595250/
https://www.ncbi.nlm.nih.gov/pubmed/34826786
http://dx.doi.org/10.1016/j.epidem.2021.100530
_version_ 1784600158435016704
author Zardini, Agnese
Galli, Margherita
Tirani, Marcello
Cereda, Danilo
Manica, Mattia
Trentini, Filippo
Guzzetta, Giorgio
Marziano, Valentina
Piccarreta, Raffaella
Melegaro, Alessia
Ajelli, Marco
Poletti, Piero
Merler, Stefano
author_facet Zardini, Agnese
Galli, Margherita
Tirani, Marcello
Cereda, Danilo
Manica, Mattia
Trentini, Filippo
Guzzetta, Giorgio
Marziano, Valentina
Piccarreta, Raffaella
Melegaro, Alessia
Ajelli, Marco
Poletti, Piero
Merler, Stefano
author_sort Zardini, Agnese
collection PubMed
description Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages defining the natural history of SARS-CoV-2 infection from 1965 SARS-CoV-2 positive individuals identified in Italy between March and April 2020 among contacts of confirmed cases. Infected contacts of cases were confirmed via RT-PCR tests as part of contact tracing activities or retrospectively via IgG serological tests and followed-up for symptoms and clinical outcomes. In addition, we provide estimates of time intervals between key events defining the clinical progression of cases as obtained from a larger sample, consisting of 95,371 infections ascertained between February and July 2020. We found that being older than 60 years of age was associated with a 39.9% (95%CI: 36.2–43.6%) likelihood of developing respiratory symptoms or fever ≥ 37.5 °C after SARS-CoV-2 infection; the 22.3% (95%CI: 19.3–25.6%) of the infections in this age group required hospital care and the 1% (95%CI: 0.4–2.1%) were admitted to an intensive care unit (ICU). The corresponding proportions in individuals younger than 60 years were estimated at 27.9% (95%CI: 25.4–30.4%), 8.8% (95%CI: 7.3–10.5%) and 0.4% (95%CI: 0.1–0.9%), respectively. The infection fatality ratio (IFR) ranged from 0.2% (95%CI: 0.0–0.6%) in individuals younger than 60 years to 12.3% (95%CI: 6.9–19.7%) for those aged 80 years or more; the case fatality ratio (CFR) in these two age classes was 0.6% (95%CI: 0.1–2%) and 19.2% (95%CI: 10.9–30.1%), respectively. The median length of stay in hospital was 10 (IQR: 3–21) days; the length of stay in ICU was 11 (IQR: 6–19) days. The obtained estimates provide insights into the epidemiology of COVID-19 and could be instrumental to refine mathematical modeling work supporting public health decisions.
format Online
Article
Text
id pubmed-8595250
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-85952502021-11-17 A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden Zardini, Agnese Galli, Margherita Tirani, Marcello Cereda, Danilo Manica, Mattia Trentini, Filippo Guzzetta, Giorgio Marziano, Valentina Piccarreta, Raffaella Melegaro, Alessia Ajelli, Marco Poletti, Piero Merler, Stefano Epidemics Article Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages defining the natural history of SARS-CoV-2 infection from 1965 SARS-CoV-2 positive individuals identified in Italy between March and April 2020 among contacts of confirmed cases. Infected contacts of cases were confirmed via RT-PCR tests as part of contact tracing activities or retrospectively via IgG serological tests and followed-up for symptoms and clinical outcomes. In addition, we provide estimates of time intervals between key events defining the clinical progression of cases as obtained from a larger sample, consisting of 95,371 infections ascertained between February and July 2020. We found that being older than 60 years of age was associated with a 39.9% (95%CI: 36.2–43.6%) likelihood of developing respiratory symptoms or fever ≥ 37.5 °C after SARS-CoV-2 infection; the 22.3% (95%CI: 19.3–25.6%) of the infections in this age group required hospital care and the 1% (95%CI: 0.4–2.1%) were admitted to an intensive care unit (ICU). The corresponding proportions in individuals younger than 60 years were estimated at 27.9% (95%CI: 25.4–30.4%), 8.8% (95%CI: 7.3–10.5%) and 0.4% (95%CI: 0.1–0.9%), respectively. The infection fatality ratio (IFR) ranged from 0.2% (95%CI: 0.0–0.6%) in individuals younger than 60 years to 12.3% (95%CI: 6.9–19.7%) for those aged 80 years or more; the case fatality ratio (CFR) in these two age classes was 0.6% (95%CI: 0.1–2%) and 19.2% (95%CI: 10.9–30.1%), respectively. The median length of stay in hospital was 10 (IQR: 3–21) days; the length of stay in ICU was 11 (IQR: 6–19) days. The obtained estimates provide insights into the epidemiology of COVID-19 and could be instrumental to refine mathematical modeling work supporting public health decisions. The Author(s). Published by Elsevier B.V. 2021-12 2021-11-17 /pmc/articles/PMC8595250/ /pubmed/34826786 http://dx.doi.org/10.1016/j.epidem.2021.100530 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zardini, Agnese
Galli, Margherita
Tirani, Marcello
Cereda, Danilo
Manica, Mattia
Trentini, Filippo
Guzzetta, Giorgio
Marziano, Valentina
Piccarreta, Raffaella
Melegaro, Alessia
Ajelli, Marco
Poletti, Piero
Merler, Stefano
A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title_full A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title_fullStr A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title_full_unstemmed A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title_short A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
title_sort quantitative assessment of epidemiological parameters required to investigate covid-19 burden
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595250/
https://www.ncbi.nlm.nih.gov/pubmed/34826786
http://dx.doi.org/10.1016/j.epidem.2021.100530
work_keys_str_mv AT zardiniagnese aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT gallimargherita aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT tiranimarcello aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT ceredadanilo aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT manicamattia aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT trentinifilippo aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT guzzettagiorgio aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT marzianovalentina aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT piccarretaraffaella aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT melegaroalessia aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT ajellimarco aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT polettipiero aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT merlerstefano aquantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT zardiniagnese quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT gallimargherita quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT tiranimarcello quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT ceredadanilo quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT manicamattia quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT trentinifilippo quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT guzzettagiorgio quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT marzianovalentina quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT piccarretaraffaella quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT melegaroalessia quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT ajellimarco quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT polettipiero quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden
AT merlerstefano quantitativeassessmentofepidemiologicalparametersrequiredtoinvestigatecovid19burden